These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 19565512

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Subclinical synovitis and tenosynovitis by ultrasonography (US) 7 score in patients with rheumatoid arthritis treated with synthetic drugs, in clinical remission by DAS28.
    Ventura-Ríos L, Sánchez Bringas G, Hernández-Díaz C, Cruz-Arenas E, Burgos-Vargas R.
    Reumatol Clin (Engl Ed); 2019; 15(5):e5-e9. PubMed ID: 29198500
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?
    Janta I, Valor L, De la Torre I, Martínez-Estupiñán L, Nieto JC, Ovalles-Bonilla JG, Martínez-Barrio J, Bello N, Hinojosa M, Montoro M, González CM, López-Longo J, Monteagudo I, Carreño L, Naredo E.
    Rheumatol Int; 2016 Mar; 36(3):387-96. PubMed ID: 26712373
    [Abstract] [Full Text] [Related]

  • 5. Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?
    Saleem B, Keen H, Goeb V, Parmar R, Nizam S, Hensor EM, Churchman SM, Quinn M, Wakefield R, Conaghan PG, Ponchel F, Emery P.
    Ann Rheum Dis; 2010 Sep; 69(9):1636-42. PubMed ID: 20421345
    [Abstract] [Full Text] [Related]

  • 6. Subclinical synovitis measured by ultrasound in rheumatoid arthritis patients with clinical remission induced by synthetic and biological modifying disease drugs.
    Cruces M, Al Snih S, Serra-Bonett N, Rivas JC.
    Reumatol Clin (Engl Ed); 2019 Sep; 15(4):218-222. PubMed ID: 29032909
    [Abstract] [Full Text] [Related]

  • 7. Correlation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agents.
    Ikeda K, Nakagomi D, Sanayama Y, Yamagata M, Okubo A, Iwamoto T, Kawashima H, Takahashi K, Nakajima H.
    J Rheumatol; 2013 Dec; 40(12):1967-76. PubMed ID: 24187096
    [Abstract] [Full Text] [Related]

  • 8. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study.
    Døhn UM, Ejbjerg B, Boonen A, Hetland ML, Hansen MS, Knudsen LS, Hansen A, Madsen OR, Hasselquist M, Møller JM, Ostergaard M.
    Ann Rheum Dis; 2011 Feb; 70(2):252-8. PubMed ID: 20980282
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
    Alivernini S, Tolusso B, Petricca L, Bui L, Di Sante G, Peluso G, Benvenuto R, Fedele AL, Federico F, Ferraccioli G, Gremese E.
    Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Grade and location of power Doppler are predictive of damage progression in rheumatoid arthritis patients in clinical remission by anti-tumour necrosis factor α.
    Raffeiner B, Grisan E, Botsios C, Stramare R, Rizzo G, Bernardi L, Punzi L, Ometto F, Doria A.
    Rheumatology (Oxford); 2017 Aug 01; 56(8):1320-1325. PubMed ID: 28431141
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients.
    Østergaard M, Emery P, Conaghan PG, Fleischmann R, Hsia EC, Xu W, Rahman MU.
    Arthritis Rheum; 2011 Dec 01; 63(12):3712-22. PubMed ID: 22127693
    [Abstract] [Full Text] [Related]

  • 15. Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort.
    Geng Y, Han J, Deng X, Zhang Z.
    Clin Rheumatol; 2014 Aug 01; 33(8):1061-6. PubMed ID: 24777468
    [Abstract] [Full Text] [Related]

  • 16. Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate.
    Kaeley GS, Nishio MJ, Goyal JR, MacCarter DK, Wells AF, Chen S, Kupper H, Kalabic J.
    Arthritis Rheumatol; 2016 Nov 01; 68(11):2584-2592. PubMed ID: 27214046
    [Abstract] [Full Text] [Related]

  • 17. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
    Wells AF, Westhovens R, Reed DM, Fanti L, Becker JC, Covucci A, Keystone EC.
    J Rheumatol; 2011 Nov 01; 38(11):2362-8. PubMed ID: 21885491
    [Abstract] [Full Text] [Related]

  • 18. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, Brown C, Fraser A, Jarret S, Emery P.
    Arthritis Rheum; 2005 Jan 01; 52(1):27-35. PubMed ID: 15641102
    [Abstract] [Full Text] [Related]

  • 19. What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis.
    Simpson E, Hock E, Stevenson M, Wong R, Dracup N, Wailoo A, Conaghan P, Estrach C, Edwards C, Wakefield R.
    Health Technol Assess; 2018 Apr 01; 22(20):1-258. PubMed ID: 29712616
    [Abstract] [Full Text] [Related]

  • 20. Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis.
    Iagnocco A, Finucci A, Ceccarelli F, Perricone C, Iorgoveanu V, Valesini G.
    Rheumatology (Oxford); 2015 Oct 01; 54(10):1890-6. PubMed ID: 26070937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.